James M. Daly


Mr. Daly brings more than 30 years of experience leading U.S. and global pharmaceutical businesses to the Board of Directors. He retired from Incyte Corporation, a biopharmaceutical company, where he served as Executive Vice President and Chief Commercial Officer from October 2012 to June 2015. Prior to Incyte, Mr. Daly served in various senior management and commercial positions at Amgen, Inc., a global pharmaceutical company, from January 2002 to December 2011. Prior to Amgen, he worked at GlaxoSmisthKline from 1985 to 2001 in various positions of increasing responsibilities. Mr. Daly serves on the board of directors of Acadia Pharmaceuticals, Inc., argenx SE, Bellicum Pharmaceuticals, Inc., and Madrigal Pharmaceuticals, Inc. Mr. Daly earned a BS degree in Pharmacy and his MBA from the University at Buffalo. Mr. Daly serves on the Audit Committee.